U.S. Tech Hardware Stock News

If you are wondering whether Kennametal's current share price lines up with its real worth, this article will walk through what the numbers suggest and what that could mean for you. With the stock at US$40.03 and returns of 4.1% over 7 days, 16.2% over 30 days, 38.1% year to date and 85.4% over 1 year, many investors are asking whether the recent performance still leaves room for value or reflects a shift in risk perceptions. Recent company updates and industry headlines have kept attention...

Boise Cascade (NYSE:BCC) acquired Holden Humphrey, expanding its distribution presence in the US Northeast. The company opened a new Greenfield Distribution Center in Texas, adding capacity and reach for its Building Materials Distribution segment. Boise Cascade recorded a $6 million legal accrual related to a Lacey Act investigation tied to its distribution business. Boise Cascade is a wood products and building materials distributor that serves dealers, homebuilders, and industrial...

TransMedics Group FY 2025 earnings snapshot TransMedics Group (TMDX) closed FY 2025 with fourth quarter revenue of US$160.8 million and basic EPS of US$3.08, alongside trailing twelve month revenue of US$605.5 million and EPS of US$5.60 that frame a much larger full year earnings base. Over the past few quarters, the company has seen revenue range from US$143.5 million to US$160.8 million while quarterly EPS moved between US$0.71 and US$3.08. This gives investors a clearer read on how higher...

Vanda Pharmaceuticals (VNDA) is back on investors’ radar after the U.S. Food and Drug Administration approved BYSANTI tablets for bipolar I disorder and schizophrenia, while an earlier imsidolimab filing for generalized pustular psoriasis also progresses through review. See our latest analysis for Vanda Pharmaceuticals. The recent FDA approvals and filings have coincided with sharp share price moves, with a 37.31% 7 day share price return and 56.23% 90 day share price return, while the 1 year...

On February 17, 2026, Sana Biotechnology appointed Brian Piper, M.B.A., as Chief Financial Officer, Executive Vice President, Treasurer, and Principal Financial Officer, ending CEO Steven Harr’s tenure as acting Principal Financial Officer. The move brings a veteran finance leader with extensive public biopharma and IPO experience into Sana’s top ranks, potentially reshaping how the company approaches capital allocation and investor engagement. We’ll explore how bringing in an experienced...

CCC Intelligent Solutions Holdings (CCCS) closed FY 2025 with Q4 revenue of US$277.9 million and basic EPS of US$0.01, while trailing twelve month figures show revenue of US$1.1 billion and basic EPS of essentially breakeven at US$0.00. Over recent quarters the company has seen revenue move from US$246.5 million in Q4 2024 to US$277.9 million in Q4 2025, with quarterly EPS ranging between a loss of US$0.03 and a profit of US$0.02. For investors, the latest print puts the spotlight squarely on...

Rocky Brands (RCKY) FY 2025 earnings snapshot Rocky Brands (RCKY) closed FY 2025 with fourth quarter revenue of US$139.7 million and basic EPS of US$0.87, supported by trailing twelve month revenue of US$482.0 million and EPS of US$2.98 as the latest earnings release hit the tape. The company has seen quarterly revenue move from US$128.1 million and EPS of US$0.64 in Q4 2024 to US$139.7 million and US$0.87 in Q4 2025. Net profit margin over the last 12 months sits at 4.6% compared with 2.5% a...

Pinterest (NYSE:PINS) is overhauling its sales and go to market approach, with management spotlighting new monetization efforts. The company is bringing in new board members to deepen its commerce and advertising capabilities. Leadership is positioning these changes as a pivot that could reshape how Pinterest turns user engagement into revenue. Pinterest sits at the intersection of visual discovery, shopping intent, and digital advertising. This keeps it closely linked to how brands spend...

Why Palvella Therapeutics Has Caught Investor Attention Recent trading in Palvella Therapeutics (PVLA) has drawn attention after a sharp share price move, with the stock closing at US$128.60 and posting very large 1 year total returns. That type of performance, together with reported annual revenue growth of 63.12% and net income growth of 54.52% on a net loss of US$32.37 million, is prompting investors to reassess how they view this clinical stage biopharmaceutical name. See our latest...

Veracyte, ticker NasdaqGM:VCYT, plans to present more than 15 abstracts from its urology portfolio at the 2026 ASCO Genitourinary Cancers Symposium. The company is preparing to launch its TrueMRD test for muscle invasive bladder cancer and continues to build out its broader genomic testing offerings. Veracyte enters this news cycle with its shares at $35.72 and a mixed return profile, including a 50.7% gain over three years alongside a 15.7% decline year to date and a 12.0% decline over the...

AXIS Capital Holdings (NYSE:AXS) announced the retirement of board member Thomas Ramey. His retirement represents a change in the company’s board-level governance structure. For you as an investor, board changes at an insurer like AXIS Capital Holdings matter because they sit close to decisions on risk appetite, capital allocation and long term priorities. The company operates in specialty insurance and reinsurance, areas that can be influenced by evolving regulation and changing views on...

AMC Entertainment Holdings (AMC) is back in focus after Muvico, a wholly owned subsidiary, launched a US$1.73b first lien notes offering tied to a new US$750m term loan and broader refinancing plans. See our latest analysis for AMC Entertainment Holdings. That refinancing announcement lands after a tough stretch for holders, with the share price at US$1.16 and recent moves including a 22.15% 30 day share price decline and a 64.42% 1 year total shareholder return loss, suggesting momentum has...

WaterBridge Infrastructure (NYSE:WBI) has announced the initiation of its first quarterly dividend, marking a new approach to capital returns. The company has also launched the open season for its Speedway Phase II Pipeline project, inviting commercial commitments for new capacity. Both announcements were released together as part of a broader update on corporate priorities and capital allocation. For investors following NYSE:WBI, these developments relate directly to how the company is...

On February 19, 2026, Zurn Elkay Water Solutions’ subsidiaries entered into Amendment No. 3 to their first lien credit agreement, refinancing existing revolving borrowings, expanding the revolving credit facility from US$200,000,000 to US$550,000,000, and extending the facility’s maturity to February 19, 2031. The revised agreement, which ties interest margins and fees to net first lien leverage and boosts remaining borrowing capacity to US$540,100,000, materially increases Zurn Elkay’s...

Sprouts Farmers Market appointed Amanda Rassi as its first chief customer officer and Don Clark as chief merchandising officer. The leadership changes signal a fresh focus on customer engagement, personalization and merchandising across the business. Investors are watching how the new C-suite structure will influence shopper loyalty and sales trends. Sprouts Farmers Market (NasdaqGS: SFM) is entering this leadership reset with a share price of $73.73. The stock has seen a 9.0% return over...

Allison Transmission Holdings (ALSN) closed out FY 2025 with Q4 revenue of US$737 million and basic EPS of US$1.19, alongside net income of US$99 million that sets the tone for how investors read the full year. The company has seen quarterly revenue move from US$824 million in Q3 2024 to US$814 million in Q2 2025, US$693 million in Q3 2025 and then US$737 million in Q4 2025. Basic EPS shifted from US$2.30 to US$2.32, US$1.63 and US$1.19 over the same stretch, giving a clear read on how top...

Navitas Semiconductor (NVTS) has just wrapped up FY 2025 with fourth quarter revenue of US$7.3 million and a basic EPS loss of US$0.14, while trailing 12 month figures show revenue of US$45.9 million and a full year EPS loss of US$0.57. Over the past few quarters, the company has seen revenue move from US$21.7 million with EPS of US$0.10 loss in Q3 2024 to US$10.1 million and EPS of US$0.09 loss in Q3 2025, alongside net income losses ranging from US$18.7 million to US$31.8 million in recent...

Merit Medical Systems (MMSI) closed FY 2025 with fourth quarter revenue of US$393.9 million and basic EPS of US$0.64, supported by trailing twelve month revenue of US$1.5 billion and EPS of US$2.17 that frame the full year picture. Over the past six reported quarters, the company has seen quarterly revenue move from US$339.8 million in Q3 2024 to US$393.9 million in Q4 2025, while quarterly basic EPS ranged between US$0.47 and US$0.64 across that stretch. With trailing net profit margin at...

Fidelity National Financial, Inc. recently reported fourth-quarter 2025 results showing revenue of US$4,051 million but a net loss of US$117 million, while also declaring a US$0.52 per-share quarterly dividend payable on March 31, 2026, to shareholders of record on March 17, 2026. Despite weaker bottom-line results and ongoing share repurchases totaling US$251.19 million for 4,427,671 shares under its current program, the company is emphasizing strong commercial activity and industry-leading...

The AES Corporation recently announced it has entered 20‑year Power Purchase Agreements with Google to develop and own co‑located energy generation for a new data center in Wilbarger County, Texas, including securing land, grid interconnection, and building shared electricity infrastructure. This long-duration partnership deepens AES’s role as an energy provider to hyperscale data centers, highlighting its capabilities in delivering tailored, on-site power and long-term energy management...

Zeta Global Holdings (ZETA) closed FY 2025 with Q4 revenue of US$394.6 million and basic EPS of US$0.03, alongside net income of US$6.5 million, setting a clear marker after a year that started in the red. Over the past four quarters, the company reported revenue increasing from US$314.7 million in Q4 2024 to US$394.6 million in Q4 2025, while basic EPS moved from US$0.07 to US$0.03. Trailing twelve month EPS stood at a loss of US$0.13, so the latest quarterly profit comes against a year that...

If you are wondering whether Infinity Natural Resources is priced attractively right now, you are not alone. This article focuses on what the current share price might mean for value-driven investors. Over the shorter term, the stock has seen a 1.5% decline over the last 7 days, a 4.3% return over 30 days and a 9.2% return year to date, while the 1-year return sits at a 14.2% decline from the previous level. These mixed returns sit against a backdrop where investors are paying closer...

If you are wondering whether M/I Homes is still good value after a strong multi year run, this article walks through how its current share price stacks up against several valuation measures. The stock closed at US$140.40 recently, with returns of 4.8% over 30 days, 9.8% year to date and 17.9% over 1 year. The 3 year return sits at a very large 138.7%, and the 5 year return at 180.7%. Recent coverage of M/I Homes has focused on its position within the U.S. homebuilding sector and how...

Over the past few years, Quanex Building Products has experienced a significant drop in operating margin, earnings per share, and return on invested capital despite continuing to grow its revenue base. This combination of rising costs and weaker profitability on a per‑share and invested‑capital basis points to mounting operational pressures and fewer attractive growth opportunities within the business. Next, we’ll examine how this sustained margin deterioration challenges Quanex’s earlier...